Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Level 42 AI has developed a non-invasive hardware/software platform that uses advanced biosensors and generative AI to analyze body-generated sounds for early detection, diagnosis, and monitoring of diseases. The company has completed five global clinical trials involving over 6,500 patients across lung, heart, and gut diseases. Its Vibrome™ platform enables earlier detection than conventional methods by capturing subtle changes in gas/fluid flow within tissues using both audible sounds and inaudible vibrations.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Level 42 AI.